CN1396271A - 采用基因芯片技术检测耐药基因 - Google Patents
采用基因芯片技术检测耐药基因 Download PDFInfo
- Publication number
- CN1396271A CN1396271A CN 01120441 CN01120441A CN1396271A CN 1396271 A CN1396271 A CN 1396271A CN 01120441 CN01120441 CN 01120441 CN 01120441 A CN01120441 A CN 01120441A CN 1396271 A CN1396271 A CN 1396271A
- Authority
- CN
- China
- Prior art keywords
- gene
- resistance
- drug resistant
- gene chip
- probe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 112
- 239000003814 drug Substances 0.000 title claims description 61
- 229940079593 drug Drugs 0.000 title claims description 53
- 238000001514 detection method Methods 0.000 title claims description 6
- 238000000034 method Methods 0.000 title abstract description 21
- 239000000523 sample Substances 0.000 claims abstract description 40
- 238000009396 hybridization Methods 0.000 claims abstract description 13
- 238000012408 PCR amplification Methods 0.000 claims abstract description 8
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract 3
- 241000894006 Bacteria Species 0.000 claims description 43
- 206010034133 Pathogen resistance Diseases 0.000 claims description 11
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 11
- 239000002773 nucleotide Substances 0.000 claims description 10
- 125000003729 nucleotide group Chemical group 0.000 claims description 10
- 108091034117 Oligonucleotide Proteins 0.000 claims description 9
- 239000007790 solid phase Substances 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 7
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 4
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 2
- 239000000969 carrier Substances 0.000 claims description 2
- 239000005357 flat glass Substances 0.000 claims description 2
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims description 2
- 239000003550 marker Substances 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 239000002985 plastic film Substances 0.000 claims description 2
- 229910052710 silicon Inorganic materials 0.000 claims description 2
- 239000010703 silicon Substances 0.000 claims description 2
- 230000000295 complement effect Effects 0.000 claims 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 abstract description 11
- 239000002751 oligonucleotide probe Substances 0.000 abstract description 11
- 230000008569 process Effects 0.000 abstract description 7
- 230000003321 amplification Effects 0.000 abstract description 5
- 238000003199 nucleic acid amplification method Methods 0.000 abstract description 5
- 101150118377 tet gene Proteins 0.000 description 47
- 239000013612 plasmid Substances 0.000 description 22
- 230000007062 hydrolysis Effects 0.000 description 20
- 238000006460 hydrolysis reaction Methods 0.000 description 20
- 102000004190 Enzymes Human genes 0.000 description 19
- 108090000790 Enzymes Proteins 0.000 description 19
- 230000003115 biocidal effect Effects 0.000 description 17
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 16
- 101710099760 Tetracycline resistance protein Proteins 0.000 description 15
- 101100288099 Streptomyces fradiae aph gene Proteins 0.000 description 14
- 108700007696 Tetrahydrofolate Dehydrogenase Proteins 0.000 description 14
- 102000004419 dihydrofolate reductase Human genes 0.000 description 14
- 108020000318 saccharopine dehydrogenase Proteins 0.000 description 13
- 108091000080 Phosphotransferase Proteins 0.000 description 12
- 102000020233 phosphotransferase Human genes 0.000 description 12
- 238000001228 spectrum Methods 0.000 description 11
- 239000000047 product Substances 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 10
- 229960001082 trimethoprim Drugs 0.000 description 10
- HZZVJAQRINQKSD-UHFFFAOYSA-N Clavulanic acid Natural products OC(=O)C1C(=CCO)OC2CC(=O)N21 HZZVJAQRINQKSD-UHFFFAOYSA-N 0.000 description 9
- 108090000364 Ligases Proteins 0.000 description 9
- 102000003960 Ligases Human genes 0.000 description 9
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 9
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 9
- 101710202686 Penicillin-sensitive transpeptidase Proteins 0.000 description 9
- HZZVJAQRINQKSD-PBFISZAISA-N clavulanic acid Chemical compound OC(=O)[C@H]1C(=C/CO)/O[C@@H]2CC(=O)N21 HZZVJAQRINQKSD-PBFISZAISA-N 0.000 description 9
- 229960003324 clavulanic acid Drugs 0.000 description 9
- 239000002853 nucleic acid probe Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- NWXMGUDVXFXRIG-WESIUVDSSA-N (4s,4as,5as,6s,12ar)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O NWXMGUDVXFXRIG-WESIUVDSSA-N 0.000 description 8
- 108020004414 DNA Proteins 0.000 description 8
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 8
- 230000001580 bacterial effect Effects 0.000 description 8
- 229960003276 erythromycin Drugs 0.000 description 8
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 8
- 229930101283 tetracycline Natural products 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- 230000000968 intestinal effect Effects 0.000 description 7
- 101150038610 penA gene Proteins 0.000 description 7
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 description 7
- 150000003952 β-lactams Chemical class 0.000 description 7
- 101710116957 D-alanyl-D-alanine carboxypeptidase Proteins 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 206010059866 Drug resistance Diseases 0.000 description 6
- 229930182555 Penicillin Natural products 0.000 description 6
- 101710205263 Peptidoglycan D,D-transpeptidase MrdA Proteins 0.000 description 6
- 101710116427 Probable peptidoglycan D,D-transpeptidase PenA Proteins 0.000 description 6
- -1 TRC-1 Chemical compound 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 108010059993 Vancomycin Proteins 0.000 description 6
- 238000013459 approach Methods 0.000 description 6
- 244000052616 bacterial pathogen Species 0.000 description 6
- 239000013256 coordination polymer Substances 0.000 description 6
- 238000009826 distribution Methods 0.000 description 6
- 229960004675 fusidic acid Drugs 0.000 description 6
- IECPWNUMDGFDKC-MZJAQBGESA-N fusidic acid Chemical compound O[C@@H]([C@@H]12)C[C@H]3\C(=C(/CCC=C(C)C)C(O)=O)[C@@H](OC(C)=O)C[C@]3(C)[C@@]2(C)CC[C@@H]2[C@]1(C)CC[C@@H](O)[C@H]2C IECPWNUMDGFDKC-MZJAQBGESA-N 0.000 description 6
- 108020004707 nucleic acids Proteins 0.000 description 6
- 102000039446 nucleic acids Human genes 0.000 description 6
- 150000007523 nucleic acids Chemical class 0.000 description 6
- 229960003165 vancomycin Drugs 0.000 description 6
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 6
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 6
- 108010077805 Bacterial Proteins Proteins 0.000 description 5
- 241000194031 Enterococcus faecium Species 0.000 description 5
- IECPWNUMDGFDKC-UHFFFAOYSA-N Fusicsaeure Natural products C12C(O)CC3C(=C(CCC=C(C)C)C(O)=O)C(OC(C)=O)CC3(C)C1(C)CCC1C2(C)CCC(O)C1C IECPWNUMDGFDKC-UHFFFAOYSA-N 0.000 description 5
- 101710164858 Lincomycin resistance protein Proteins 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 229960002518 gentamicin Drugs 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 229940049954 penicillin Drugs 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 229940124530 sulfonamide Drugs 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 125000002124 5'-adenosyl group Chemical group N1=CN=C2N(C=NC2=C1N)[C@H]1[C@H](O)[C@H](O)[C@H](O1)C* 0.000 description 4
- XHCNINMOALIGKM-UHFFFAOYSA-N 5,5,7,12,12,14-hexamethyl-1,4,8,11-tetrazacyclotetradecane Chemical compound CC1CC(C)(C)NCCNC(C)CC(C)(C)NCCN1 XHCNINMOALIGKM-UHFFFAOYSA-N 0.000 description 4
- 101100008058 Canis lupus familiaris CUX1 gene Proteins 0.000 description 4
- 108010054814 DNA Gyrase Proteins 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 4
- 229930182566 Gentamicin Natural products 0.000 description 4
- 102100024933 Protein CASP Human genes 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 4
- 102000004357 Transferases Human genes 0.000 description 4
- 108090000992 Transferases Proteins 0.000 description 4
- 101150114167 ampC gene Proteins 0.000 description 4
- RTYJTGSCYUUYAL-YCAHSCEMSA-L carbenicillin disodium Chemical compound [Na+].[Na+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)C(C([O-])=O)C1=CC=CC=C1 RTYJTGSCYUUYAL-YCAHSCEMSA-L 0.000 description 4
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 4
- 210000000349 chromosome Anatomy 0.000 description 4
- 108010014404 dihydrofolate synthetase Proteins 0.000 description 4
- 238000002372 labelling Methods 0.000 description 4
- 101150114824 lmrB gene Proteins 0.000 description 4
- 229960005322 streptomycin Drugs 0.000 description 4
- 108010008664 streptomycin 3''-kinase Proteins 0.000 description 4
- 229960005404 sulfamethoxazole Drugs 0.000 description 4
- JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 description 4
- 101150114434 vanA gene Proteins 0.000 description 4
- 101100242924 Bacillus subtilis (strain 168) pbpF gene Proteins 0.000 description 3
- 101150074155 DHFR gene Proteins 0.000 description 3
- 101150048270 DHPS gene Proteins 0.000 description 3
- 102000004594 DNA Polymerase I Human genes 0.000 description 3
- 108010017826 DNA Polymerase I Proteins 0.000 description 3
- 238000000018 DNA microarray Methods 0.000 description 3
- 241000588697 Enterobacter cloacae Species 0.000 description 3
- 101100102350 Enterococcus faecium vanH gene Proteins 0.000 description 3
- 101000740462 Escherichia coli Beta-lactamase TEM Proteins 0.000 description 3
- 201000008225 Klebsiella pneumonia Diseases 0.000 description 3
- 241000588747 Klebsiella pneumoniae Species 0.000 description 3
- OJMMVQQUTAEWLP-UHFFFAOYSA-N Lincomycin Natural products CN1CC(CCC)CC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 OJMMVQQUTAEWLP-UHFFFAOYSA-N 0.000 description 3
- 206010035717 Pneumonia klebsiella Diseases 0.000 description 3
- 108010064250 RNA polymerase beta subunit Proteins 0.000 description 3
- URWAJWIAIPFPJE-UHFFFAOYSA-N Rickamicin Natural products O1CC(O)(C)C(NC)C(O)C1OC1C(O)C(OC2C(CC=C(CN)O2)N)C(N)CC1N URWAJWIAIPFPJE-UHFFFAOYSA-N 0.000 description 3
- 101100242909 Streptococcus pneumoniae (strain ATCC BAA-255 / R6) pbpA gene Proteins 0.000 description 3
- 101150014550 aadB gene Proteins 0.000 description 3
- 229940126575 aminoglycoside Drugs 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- BIDUPMYXGFNAEJ-APGVDKLISA-N astromicin Chemical compound O[C@@H]1[C@H](N(C)C(=O)CN)[C@@H](OC)[C@@H](O)[C@H](N)[C@H]1O[C@@H]1[C@H](N)CC[C@@H]([C@H](C)N)O1 BIDUPMYXGFNAEJ-APGVDKLISA-N 0.000 description 3
- WZOZEZRFJCJXNZ-ZBFHGGJFSA-N cefoxitin Chemical compound N([C@]1(OC)C(N2C(=C(COC(N)=O)CS[C@@H]21)C(O)=O)=O)C(=O)CC1=CC=CS1 WZOZEZRFJCJXNZ-ZBFHGGJFSA-N 0.000 description 3
- 229960002682 cefoxitin Drugs 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- JQXXHWHPUNPDRT-BQVAUQFYSA-N chembl1523493 Chemical compound O([C@](C1=O)(C)O\C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C\C=C(C)/C(=O)NC=2C(O)=C3C(O)=C4C)C)OC)C4=C1C3=C(O)C=2C=NN1CCN(C)CC1 JQXXHWHPUNPDRT-BQVAUQFYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 3
- 101150070420 gyrA gene Proteins 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- XUWPJKDMEZSVTP-LTYMHZPRSA-N kalafungina Chemical compound O=C1C2=C(O)C=CC=C2C(=O)C2=C1[C@@H](C)O[C@H]1[C@@H]2OC(=O)C1 XUWPJKDMEZSVTP-LTYMHZPRSA-N 0.000 description 3
- OJMMVQQUTAEWLP-KIDUDLJLSA-N lincomycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 OJMMVQQUTAEWLP-KIDUDLJLSA-N 0.000 description 3
- 229960005287 lincomycin Drugs 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 101150058012 mrcA gene Proteins 0.000 description 3
- 229940049547 paraxin Drugs 0.000 description 3
- 101150105325 ponA gene Proteins 0.000 description 3
- 108010042660 rRNA (adenosine-O-2'-)methyltransferase Proteins 0.000 description 3
- 229960001225 rifampicin Drugs 0.000 description 3
- URWAJWIAIPFPJE-YFMIWBNJSA-N sisomycin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC=C(CN)O2)N)[C@@H](N)C[C@H]1N URWAJWIAIPFPJE-YFMIWBNJSA-N 0.000 description 3
- 150000003456 sulfonamides Chemical class 0.000 description 3
- 101150045159 tetB gene Proteins 0.000 description 3
- XEQLFNPSYWZPOW-NUOYRARPSA-N (2r)-4-amino-n-[(1r,2s,3r,4r,5s)-5-amino-4-[(2r,3r,4r,5s,6r)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-2-hydroxycyclohexyl]-2-hydroxybutanamide Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O[C@@H]1[C@@H]([C@H](O)[C@@H](CO)O1)O)O)NC(=O)[C@H](O)CCN)[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1N XEQLFNPSYWZPOW-NUOYRARPSA-N 0.000 description 2
- LHNIIDJCEODSHA-OQRUQETBSA-N (6r,7r)-3-[(e)-2-(2,4-dinitrophenyl)ethenyl]-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound N([C@H]1[C@H]2SCC(=C(N2C1=O)C(=O)O)\C=C\C=1C(=CC(=CC=1)[N+]([O-])=O)[N+]([O-])=O)C(=O)CC1=CC=CS1 LHNIIDJCEODSHA-OQRUQETBSA-N 0.000 description 2
- WZPBZJONDBGPKJ-UHFFFAOYSA-N Antibiotic SQ 26917 Natural products O=C1N(S(O)(=O)=O)C(C)C1NC(=O)C(=NOC(C)(C)C(O)=O)C1=CSC(N)=N1 WZPBZJONDBGPKJ-UHFFFAOYSA-N 0.000 description 2
- 102100024746 Dihydrofolate reductase Human genes 0.000 description 2
- 241000588921 Enterobacteriaceae Species 0.000 description 2
- 241000194033 Enterococcus Species 0.000 description 2
- 101000708573 Homo sapiens Y+L amino acid transporter 2 Proteins 0.000 description 2
- 229930183998 Lividomycin Natural products 0.000 description 2
- 101100038261 Methanococcus vannielii (strain ATCC 35089 / DSM 1224 / JCM 13029 / OCM 148 / SB) rpo2C gene Proteins 0.000 description 2
- 102000003832 Nucleotidyltransferases Human genes 0.000 description 2
- 108090000119 Nucleotidyltransferases Proteins 0.000 description 2
- KYGZCKSPAKDVKC-UHFFFAOYSA-N Oxolinic acid Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC2=C1OCO2 KYGZCKSPAKDVKC-UHFFFAOYSA-N 0.000 description 2
- 101710096750 Penicillin-binding protein 2B Proteins 0.000 description 2
- 102000010562 Peptide Elongation Factor G Human genes 0.000 description 2
- 108010077742 Peptide Elongation Factor G Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 241000607715 Serratia marcescens Species 0.000 description 2
- 229930192786 Sisomicin Natural products 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
- 102100032803 Y+L amino acid transporter 2 Human genes 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 125000003368 amide group Chemical group 0.000 description 2
- 229960004821 amikacin Drugs 0.000 description 2
- LKCWBDHBTVXHDL-RMDFUYIESA-N amikacin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O1)O)NC(=O)[C@@H](O)CCN)[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1O LKCWBDHBTVXHDL-RMDFUYIESA-N 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000001715 anti-suppressor Effects 0.000 description 2
- 229950006334 apramycin Drugs 0.000 description 2
- 229950004074 astromicin Drugs 0.000 description 2
- WZPBZJONDBGPKJ-VEHQQRBSSA-N aztreonam Chemical compound O=C1N(S([O-])(=O)=O)[C@@H](C)[C@@H]1NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC([NH3+])=N1 WZPBZJONDBGPKJ-VEHQQRBSSA-N 0.000 description 2
- 229960003644 aztreonam Drugs 0.000 description 2
- 101150049515 bla gene Proteins 0.000 description 2
- 229950004527 butirosin Drugs 0.000 description 2
- CZTQZXZIADLWOZ-CRAIPNDOSA-N cefaloridine Chemical compound O=C([C@@H](NC(=O)CC=1SC=CC=1)[C@H]1SC2)N1C(C(=O)[O-])=C2C[N+]1=CC=CC=C1 CZTQZXZIADLWOZ-CRAIPNDOSA-N 0.000 description 2
- 229960003866 cefaloridine Drugs 0.000 description 2
- ORFOPKXBNMVMKC-DWVKKRMSSA-N ceftazidime Chemical compound S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)NC(=O)\C(=N/OC(C)(C)C(O)=O)C=2N=C(N)SC=2)CC=1C[N+]1=CC=CC=C1 ORFOPKXBNMVMKC-DWVKKRMSSA-N 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 2
- 229960003326 cloxacillin Drugs 0.000 description 2
- LQOLIRLGBULYKD-JKIFEVAISA-N cloxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=CC=CC=C1Cl LQOLIRLGBULYKD-JKIFEVAISA-N 0.000 description 2
- 108091036078 conserved sequence Proteins 0.000 description 2
- 239000006059 cover glass Substances 0.000 description 2
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 2
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 2
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 2
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 2
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 2
- 229960003807 dibekacin Drugs 0.000 description 2
- JJCQSGDBDPYCEO-XVZSLQNASA-N dibekacin Chemical compound O1[C@H](CN)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N JJCQSGDBDPYCEO-XVZSLQNASA-N 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229940124307 fluoroquinolone Drugs 0.000 description 2
- 101150064107 fosB gene Proteins 0.000 description 2
- 101150013736 gyrB gene Proteins 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 125000000842 isoxazolyl group Chemical group 0.000 description 2
- 229950003076 lividomycin Drugs 0.000 description 2
- DBLVDAUGBTYDFR-SWMBIRFSSA-N lividomycin A Chemical compound O([C@@H]1[C@@H](N)C[C@@H](N)[C@H](O)[C@H]1O[C@@H]1O[C@H](CO)[C@H]([C@H]1O)O[C@H]1O[C@H]([C@H]([C@H](O)[C@H]1N)O[C@@H]1[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)CN)[C@H]1O[C@H](CO)[C@@H](O)C[C@H]1N DBLVDAUGBTYDFR-SWMBIRFSSA-N 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- YJQPYGGHQPGBLI-KGSXXDOSSA-N novobiocin Chemical compound O1C(C)(C)[C@H](OC)[C@@H](OC(N)=O)[C@@H](O)[C@@H]1OC1=CC=C(C(O)=C(NC(=O)C=2C=C(CC=C(C)C)C(O)=CC=2)C(=O)O2)C2=C1C YJQPYGGHQPGBLI-KGSXXDOSSA-N 0.000 description 2
- UWYHMGVUTGAWSP-JKIFEVAISA-N oxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=CC=CC=C1 UWYHMGVUTGAWSP-JKIFEVAISA-N 0.000 description 2
- 101150012629 parE gene Proteins 0.000 description 2
- 229940056360 penicillin g Drugs 0.000 description 2
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 2
- 239000003306 quinoline derived antiinfective agent Substances 0.000 description 2
- 101710108032 rRNA adenine N-6-methyltransferase Proteins 0.000 description 2
- 239000011535 reaction buffer Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229960003485 ribostamycin Drugs 0.000 description 2
- 229930190553 ribostamycin Natural products 0.000 description 2
- NSKGQURZWSPSBC-NLZFXWNVSA-N ribostamycin Chemical compound N[C@H]1[C@H](O)[C@@H](O)[C@H](CN)O[C@@H]1O[C@@H]1[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@H](CO)O2)O)[C@H](O)[C@@H](N)C[C@H]1N NSKGQURZWSPSBC-NLZFXWNVSA-N 0.000 description 2
- NSKGQURZWSPSBC-UHFFFAOYSA-N ribostamycin A Natural products NC1C(O)C(O)C(CN)OC1OC1C(OC2C(C(O)C(CO)O2)O)C(O)C(N)CC1N NSKGQURZWSPSBC-UHFFFAOYSA-N 0.000 description 2
- 101150085857 rpo2 gene Proteins 0.000 description 2
- 101150090202 rpoB gene Proteins 0.000 description 2
- 229960005456 sisomicin Drugs 0.000 description 2
- 229960000268 spectinomycin Drugs 0.000 description 2
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 2
- QTENRWWVYAAPBI-YCRXJPFRSA-N streptomycin sulfate Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O QTENRWWVYAAPBI-YCRXJPFRSA-N 0.000 description 2
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 2
- 101150015970 tetM gene Proteins 0.000 description 2
- 229960002180 tetracycline Drugs 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 229940072172 tetracycline antibiotic Drugs 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- 101150037181 vanB gene Proteins 0.000 description 2
- OMNVYXHOSHNURL-PSASIEDQSA-N (2r)-2-[[(2r)-2-azaniumylpropanoyl]amino]-3-phenylpropanoate Chemical compound C[C@@H]([NH3+])C(=O)N[C@@H](C([O-])=O)CC1=CC=CC=C1 OMNVYXHOSHNURL-PSASIEDQSA-N 0.000 description 1
- URWAJWIAIPFPJE-VHLNBGGKSA-N (2r,3r,4r,5r)-2-[(1s,2r,3r,4s,6r)-4,6-diamino-3-[[(2s,3r)-3-amino-6-(aminomethyl)-3,4-dihydro-2h-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@H](O)[C@H](O[C@@H]2[C@@H](CC=C(CN)O2)N)[C@@H](N)C[C@H]1N URWAJWIAIPFPJE-VHLNBGGKSA-N 0.000 description 1
- DRKCFEIKVASKQV-HWJHIZAWSA-N (2s,3s,4s,5r,6s)-4-amino-2-[2-[2-[2-[2-[[(2s,3s,4s,5r,6s)-4-amino-6-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,5s,6r)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-3,5-dihydroxyoxan-2-yl]methylsulfanyl]ethoxy]ethyldisulfanyl]ethoxy]e Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CSCCOCCSSCCOCCSC[C@@H]3[C@H]([C@H](N)[C@@H](O)[C@@H](O[C@@H]4[C@H]([C@H](O[C@@H]5[C@@H](C[C@H](O)[C@@H](CN)O5)N)[C@@H](N)C[C@H]4N)O)O3)O)O2)O)[C@H](N)C[C@@H]1N DRKCFEIKVASKQV-HWJHIZAWSA-N 0.000 description 1
- 101710189343 2''-aminoglycoside nucleotidyltransferase Proteins 0.000 description 1
- 108030003727 2'-phosphotransferases Proteins 0.000 description 1
- SYQNUQSGEWNWKV-XUIVZRPNSA-N 4-hydroxy-3,5-dimethyl-5-(2-methyl-buta-1,3-dienyl)-5h-thiophen-2-one Chemical compound C=CC(/C)=C/[C@@]1(C)SC(=O)C(C)=C1O SYQNUQSGEWNWKV-XUIVZRPNSA-N 0.000 description 1
- YVMBAUWDIGJRNY-BESUKNQGSA-N 4o8o7q7iu4 Chemical compound C1C(=O)C[C@H](O)\C=C(/C)\C=C\CNC(=O)\C=C\[C@@H](C)[C@@H](C(C)C)OC(=O)C2=CCCN2C(=O)C2=COC1=N2.N([C@@H]1C(=O)N[C@@H](C(N2CCC[C@H]2C(=O)N(C)[C@@H](CC=2C=CC(=CC=2)N(C)C)C(=O)N2CCC(=O)C[C@H]2C(=O)N[C@H](C(=O)O[C@@H]1C)C=1C=CC=CC=1)=O)CC)C(=O)C1=NC=CC=C1O YVMBAUWDIGJRNY-BESUKNQGSA-N 0.000 description 1
- SYQNUQSGEWNWKV-UHFFFAOYSA-N 5R-Thiolactomycin Natural products C=CC(C)=CC1(C)SC(=O)C(C)=C1O SYQNUQSGEWNWKV-UHFFFAOYSA-N 0.000 description 1
- 101150103244 ACT1 gene Proteins 0.000 description 1
- 229930191874 Aburamycin Natural products 0.000 description 1
- 241000589291 Acinetobacter Species 0.000 description 1
- 101001091240 Acinetobacter baumannii Aminoglycoside 3'-phosphotransferase Proteins 0.000 description 1
- 101100214700 Acinetobacter baumannii aacC2 gene Proteins 0.000 description 1
- 241001148231 Acinetobacter haemolyticus Species 0.000 description 1
- 108700016155 Acyl transferases Proteins 0.000 description 1
- 102000057234 Acyl transferases Human genes 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- 101710153593 Albumin A Proteins 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- 241001550224 Apha Species 0.000 description 1
- MQTOSJVFKKJCRP-HHZDEWPHSA-N Azythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@H]([C@@]([C@H](O)[C@H](C)N(C)C[C@@H](C)C[C@](C)(O)[C@@H](O[C@@H]2[C@H]([C@@H](C[C@H](C)O2)N(C)C)O)[C@@H]1C)(C)O)CC)[C@@H]1C[C@](C)(OC)[C@H](O)[C@@H](C)O1 MQTOSJVFKKJCRP-HHZDEWPHSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000193752 Bacillus circulans Species 0.000 description 1
- 101100445532 Bacillus licheniformis ermK gene Proteins 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 101000735340 Bacillus subtilis (strain 168) Penicillin-binding protein 2B Proteins 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- 108020004256 Beta-lactamase Proteins 0.000 description 1
- 229910000906 Bronze Inorganic materials 0.000 description 1
- 229930183180 Butirosin Natural products 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 101100148729 Caenorhabditis elegans sar-1 gene Proteins 0.000 description 1
- 241000589875 Campylobacter jejuni Species 0.000 description 1
- 101100288101 Campylobacter jejuni aphA-7 gene Proteins 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- 101100227595 Chlamydia pneumoniae folKP gene Proteins 0.000 description 1
- 241001019179 Cingula Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 108010056652 D-2-hydroxyacid dehydrogenase Proteins 0.000 description 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N D-alanine Chemical compound C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 1
- 101710105693 D-alanyl-D-alanine carboxypeptidase DacA Proteins 0.000 description 1
- 101710105699 D-alanyl-D-alanine carboxypeptidase DacB Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 108090000323 DNA Topoisomerases Proteins 0.000 description 1
- 102000003915 DNA Topoisomerases Human genes 0.000 description 1
- 101000963506 Danio rerio Methionine-R-sulfoxide reductase B1-A Proteins 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 101100191017 Dictyostelium discoideum ponB gene Proteins 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- 101100435497 Drosophila melanogaster ari-1 gene Proteins 0.000 description 1
- 101000740458 Enterobacter cloacae Imipenem-hydrolyzing beta-lactamase Proteins 0.000 description 1
- 101000925662 Enterobacteria phage PRD1 Endolysin Proteins 0.000 description 1
- 101100049034 Enterococcus faecalis (strain ATCC 700802 / V583) vanXB gene Proteins 0.000 description 1
- 101100102341 Enterococcus gallinarum vanC gene Proteins 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- 101100288094 Escherichia coli aphA1 gene Proteins 0.000 description 1
- 101100171531 Escherichia coli dhfrIX gene Proteins 0.000 description 1
- 101100171528 Escherichia coli dhfrVII gene Proteins 0.000 description 1
- 101100206300 Escherichia coli tetC gene Proteins 0.000 description 1
- 101500000138 Escherichia phage P1 Antirepressor protein 2 Proteins 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 229930195503 Fortimicin Natural products 0.000 description 1
- 101100161918 Glycine max SAC1 gene Proteins 0.000 description 1
- 101001119251 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) 30S ribosomal protein S12 Proteins 0.000 description 1
- 101100332575 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) folA gene Proteins 0.000 description 1
- 101100077927 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) mrdA gene Proteins 0.000 description 1
- 108010072039 Histidine kinase Proteins 0.000 description 1
- 101000665449 Homo sapiens RNA binding protein fox-1 homolog 1 Proteins 0.000 description 1
- 101000648224 Homo sapiens Syntaxin-8 Proteins 0.000 description 1
- 101000669432 Homo sapiens Transducin-like enhancer protein 1 Proteins 0.000 description 1
- 101710150697 Inositol monophosphatase 1 Proteins 0.000 description 1
- 101710126181 Insulin-like growth factor 2 mRNA-binding protein 1 Proteins 0.000 description 1
- 108010044467 Isoenzymes Proteins 0.000 description 1
- 108010025815 Kanamycin Kinase Proteins 0.000 description 1
- 241000588915 Klebsiella aerogenes Species 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 241000193386 Lysinibacillus sphaericus Species 0.000 description 1
- 102100021948 Lysyl oxidase homolog 2 Human genes 0.000 description 1
- 101150052154 MSRA1 gene Proteins 0.000 description 1
- 241000187708 Micromonospora Species 0.000 description 1
- 102100029083 Minor histocompatibility antigen H13 Human genes 0.000 description 1
- 206010073150 Multiple endocrine neoplasia Type 1 Diseases 0.000 description 1
- 101100063392 Mycobacterium leprae (strain TN) folP1 gene Proteins 0.000 description 1
- 101710202061 N-acetyltransferase Proteins 0.000 description 1
- 241000588653 Neisseria Species 0.000 description 1
- 241000588652 Neisseria gonorrhoeae Species 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 101100327416 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) cef-1 gene Proteins 0.000 description 1
- YJQPYGGHQPGBLI-UHFFFAOYSA-N Novobiocin Natural products O1C(C)(C)C(OC)C(OC(N)=O)C(O)C1OC1=CC=C(C(O)=C(NC(=O)C=2C=C(CC=C(C)C)C(O)=CC=2)C(=O)O2)C2=C1C YJQPYGGHQPGBLI-UHFFFAOYSA-N 0.000 description 1
- UOZODPSAJZTQNH-UHFFFAOYSA-N Paromomycin II Natural products NC1C(O)C(O)C(CN)OC1OC1C(O)C(OC2C(C(N)CC(N)C2O)OC2C(C(O)C(O)C(CO)O2)N)OC1CO UOZODPSAJZTQNH-UHFFFAOYSA-N 0.000 description 1
- 101710096749 Penicillin-binding protein 2A Proteins 0.000 description 1
- 101710096751 Penicillin-binding protein 2x Proteins 0.000 description 1
- 101710167890 Penicillin-binding protein 4 Proteins 0.000 description 1
- 102100033422 Pericentriolar material 1 protein Human genes 0.000 description 1
- 101710095344 Pericentriolar material 1 protein Proteins 0.000 description 1
- 101710159752 Poly(3-hydroxyalkanoate) polymerase subunit PhaE Proteins 0.000 description 1
- 108010079780 Pristinamycin Proteins 0.000 description 1
- RLNUPSVMIYRZSM-UHFFFAOYSA-N Pristinamycin Natural products CC1OC(=O)C(C=2C=CC=CC=2)NC(=O)C2CC(=O)CCN2C(=O)C(CC=2C=CC(=CC=2)N(C)C)CCN(C)C(=O)C2CCCN2C(=O)C(CC)NC(=O)C1NC(=O)C1=NC=CC=C1O RLNUPSVMIYRZSM-UHFFFAOYSA-N 0.000 description 1
- 101710130262 Probable Vpr-like protein Proteins 0.000 description 1
- 102100034014 Prolyl 3-hydroxylase 3 Human genes 0.000 description 1
- 101100004561 Proteus vulgaris blaB gene Proteins 0.000 description 1
- 241000588778 Providencia stuartii Species 0.000 description 1
- 101000744412 Pseudomonas aeruginosa Aminoglycoside N(3)-acetyltransferase III Proteins 0.000 description 1
- 101100214699 Pseudomonas aeruginosa aacC1 gene Proteins 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 101710202103 Putative beta-lactamase HcpD Proteins 0.000 description 1
- 102100038188 RNA binding protein fox-1 homolog 1 Human genes 0.000 description 1
- 101000605024 Rattus norvegicus Large neutral amino acids transporter small subunit 1 Proteins 0.000 description 1
- MEFKEPWMEQBLKI-AIRLBKTGSA-N S-adenosyl-L-methioninate Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H](N)C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-N 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 101000869486 Salmonella typhimurium (strain LT2 / SGSC1412 / ATCC 700720) Aminoglycoside (3'') (9) adenylyltransferase Proteins 0.000 description 1
- 101100054091 Schizosaccharomyces pombe (strain 972 / ATCC 24843) par2 gene Proteins 0.000 description 1
- 101100445533 Staphylococcus epidermidis ermM gene Proteins 0.000 description 1
- 101100064533 Staphylococcus haemolyticus dfrD gene Proteins 0.000 description 1
- 101001091241 Streptomyces fradiae Aminoglycoside 3'-phosphotransferase Proteins 0.000 description 1
- 241000187392 Streptomyces griseus Species 0.000 description 1
- 101100055820 Streptomyces griseus aphE gene Proteins 0.000 description 1
- 101100038645 Streptomyces griseus rppA gene Proteins 0.000 description 1
- 101100043719 Streptomyces griseus strB1 gene Proteins 0.000 description 1
- 241000187391 Streptomyces hygroscopicus Species 0.000 description 1
- 241001600133 Streptomyces ribosidificus Species 0.000 description 1
- 241001655322 Streptomycetales Species 0.000 description 1
- 241001455617 Sula Species 0.000 description 1
- 102100028808 Syntaxin-8 Human genes 0.000 description 1
- WKDDRNSBRWANNC-UHFFFAOYSA-N Thienamycin Natural products C1C(SCCN)=C(C(O)=O)N2C(=O)C(C(O)C)C21 WKDDRNSBRWANNC-UHFFFAOYSA-N 0.000 description 1
- 102100039362 Transducin-like enhancer protein 1 Human genes 0.000 description 1
- 101150016019 aacA4 gene Proteins 0.000 description 1
- 101150100833 aacC3 gene Proteins 0.000 description 1
- RQEUIHLBZLSDQY-XXHIGGRKSA-N aburamycin Chemical compound O([C@@H]1CC(O[C@H](C)[C@@H]1OC(C)=O)OC=1C=C2C=C3CC(C(C(=O)C3=C(O)C2=C(O)C=1C)OC1O[C@H](C)[C@@H](O)[C@H](OC2O[C@H](C)[C@@H](O)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@](C)(O)C3)C2)C1)[C@H](OC)C(=O)[C@@H](O)[C@@H](C)O)[C@@H]1C[C@@H](O)[C@@H](OC)[C@@H](C)O1 RQEUIHLBZLSDQY-XXHIGGRKSA-N 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 108020002494 acetyltransferase Proteins 0.000 description 1
- 102000005421 acetyltransferase Human genes 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 229960001570 ademetionine Drugs 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 230000006154 adenylylation Effects 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- XZNUGFQTQHRASN-XQENGBIVSA-N apramycin Chemical compound O([C@H]1O[C@@H]2[C@H](O)[C@@H]([C@H](O[C@H]2C[C@H]1N)O[C@@H]1[C@@H]([C@@H](O)[C@H](N)[C@@H](CO)O1)O)NC)[C@@H]1[C@@H](N)C[C@@H](N)[C@H](O)[C@H]1O XZNUGFQTQHRASN-XQENGBIVSA-N 0.000 description 1
- OIRDTQYFTABQOQ-UHFFFAOYSA-N ara-adenosine Natural products Nc1ncnc2n(cnc12)C1OC(CO)C(O)C1O OIRDTQYFTABQOQ-UHFFFAOYSA-N 0.000 description 1
- 210000003578 bacterial chromosome Anatomy 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 101150100090 blaB gene Proteins 0.000 description 1
- 101150068326 bro1 gene Proteins 0.000 description 1
- 239000010974 bronze Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 1
- 229960003669 carbenicillin Drugs 0.000 description 1
- XIURVHNZVLADCM-IUODEOHRSA-N cefalotin Chemical compound N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC(=O)C)C(O)=O)C(=O)CC1=CC=CS1 XIURVHNZVLADCM-IUODEOHRSA-N 0.000 description 1
- 229960000603 cefalotin Drugs 0.000 description 1
- 229960000484 ceftazidime Drugs 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 101150024470 cfxA gene Proteins 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- 229960003405 ciprofloxacin Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 229960002227 clindamycin Drugs 0.000 description 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
- KUNSUQLRTQLHQQ-UHFFFAOYSA-N copper tin Chemical compound [Cu].[Sn] KUNSUQLRTQLHQQ-UHFFFAOYSA-N 0.000 description 1
- 101150084095 ddpX gene Proteins 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 101150109314 dhfrVIII gene Proteins 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- DOBMPNYZJYQDGZ-UHFFFAOYSA-N dicoumarol Chemical compound C1=CC=CC2=C1OC(=O)C(CC=1C(OC3=CC=CC=C3C=1O)=O)=C2O DOBMPNYZJYQDGZ-UHFFFAOYSA-N 0.000 description 1
- 108020001096 dihydrofolate reductase Proteins 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 101150117890 emrB gene Proteins 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 101150071309 ermBP gene Proteins 0.000 description 1
- 101150016744 ermC gene Proteins 0.000 description 1
- 108010031115 erythromycin esterase Proteins 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 101150045875 folP gene Proteins 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- YQYJSBFKSSDGFO-FWAVGLHBSA-N hygromycin A Chemical compound O[C@H]1[C@H](O)[C@H](C(=O)C)O[C@@H]1Oc1ccc(\C=C(/C)C(=O)N[C@@H]2[C@@H]([C@H]3OCO[C@H]3[C@@H](O)[C@@H]2O)O)cc1O YQYJSBFKSSDGFO-FWAVGLHBSA-N 0.000 description 1
- 229960002182 imipenem Drugs 0.000 description 1
- ZSKVGTPCRGIANV-ZXFLCMHBSA-N imipenem Chemical compound C1C(SCC\N=C\N)=C(C(O)=O)N2C(=O)[C@H]([C@H](O)C)[C@H]21 ZSKVGTPCRGIANV-ZXFLCMHBSA-N 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229960000798 isepamicin Drugs 0.000 description 1
- UDIIBEDMEYAVNG-ZKFPOVNWSA-N isepamicin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)O)[C@@H](N)C[C@H]1NC(=O)[C@@H](O)CN UDIIBEDMEYAVNG-ZKFPOVNWSA-N 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 101150052643 lmrA gene Proteins 0.000 description 1
- 101150093674 lpxD gene Proteins 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 101150071231 mecR1 gene Proteins 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 108091028606 miR-1 stem-loop Proteins 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 101150116543 mrcB gene Proteins 0.000 description 1
- 101150021123 msrA gene Proteins 0.000 description 1
- 101150114366 msrA2 gene Proteins 0.000 description 1
- 101150006794 msrAB gene Proteins 0.000 description 1
- 101150109310 msrAB1 gene Proteins 0.000 description 1
- 101150052209 msrAB2 gene Proteins 0.000 description 1
- 101150068440 msrB gene Proteins 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229960000210 nalidixic acid Drugs 0.000 description 1
- MHWLWQUZZRMNGJ-UHFFFAOYSA-N nalidixic acid Chemical compound C1=C(C)N=C2N(CC)C=C(C(O)=O)C(=O)C2=C1 MHWLWQUZZRMNGJ-UHFFFAOYSA-N 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 229960000808 netilmicin Drugs 0.000 description 1
- ZBGPYVZLYBDXKO-HILBYHGXSA-N netilmycin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@]([C@H](NC)[C@@H](O)CO1)(C)O)NCC)[C@H]1OC(CN)=CC[C@H]1N ZBGPYVZLYBDXKO-HILBYHGXSA-N 0.000 description 1
- 229960002950 novobiocin Drugs 0.000 description 1
- RZPAKFUAFGMUPI-QESOVKLGSA-N oleandomycin Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](C)C(=O)O[C@H](C)[C@H](C)[C@H](O)[C@@H](C)C(=O)[C@@]2(OC2)C[C@H](C)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C RZPAKFUAFGMUPI-QESOVKLGSA-N 0.000 description 1
- 229960001019 oxacillin Drugs 0.000 description 1
- 229960001914 paromomycin Drugs 0.000 description 1
- UOZODPSAJZTQNH-LSWIJEOBSA-N paromomycin Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)O[C@@H]1CO UOZODPSAJZTQNH-LSWIJEOBSA-N 0.000 description 1
- 238000002161 passivation Methods 0.000 description 1
- 101150018609 pbp2a gene Proteins 0.000 description 1
- 235000019371 penicillin G benzathine Nutrition 0.000 description 1
- 150000002960 penicillins Chemical class 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 229960003961 pristinamycin Drugs 0.000 description 1
- YGXCETJZBDTKRY-DZCVGBHJSA-N pristinamycin IA Chemical group N([C@@H]1C(=O)N[C@@H](C(N2CCC[C@H]2C(=O)N(C)[C@@H](CC=2C=CC(=CC=2)N(C)C)C(=O)N2CCC(=O)C[C@H]2C(=O)N[C@H](C(=O)O[C@@H]1C)C=1C=CC=CC=1)=O)CC)C(=O)C1=NC=CC=C1O YGXCETJZBDTKRY-DZCVGBHJSA-N 0.000 description 1
- DAIKHDNSXMZDCU-OUDXUNEISA-N pristinamycin-IIA Natural products CC(C)[C@H]1OC(=O)C2=CCCN2C(=O)c3coc(CC(=O)C[C@H](O)C=C(C)C=CCNC(=O)C=C[C@@H]1C)n3 DAIKHDNSXMZDCU-OUDXUNEISA-N 0.000 description 1
- JOOMGSFOCRDAHL-XKCHLWDXSA-N pristinamycin-IIB Natural products CC(C)[C@@H]1OC(=O)[C@H]2CCCN2C(=O)c3coc(CC(=O)C[C@@H](O)C=C(C)C=CCNC(=O)C=C[C@H]1C)n3 JOOMGSFOCRDAHL-XKCHLWDXSA-N 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 101150025975 qacA gene Proteins 0.000 description 1
- 150000007660 quinolones Chemical class 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008261 resistance mechanism Effects 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000011218 segmentation Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000006557 surface reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 101150078180 tetL gene Proteins 0.000 description 1
- 101150061166 tetR gene Proteins 0.000 description 1
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 229960000707 tobramycin Drugs 0.000 description 1
- NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 description 1
- 229940043263 traditional drug Drugs 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
- 229940045145 uridine Drugs 0.000 description 1
- 101150096103 vanX gene Proteins 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
耐药基因名称 | 编号 | 探针序列 | 引物序列 |
氨基糖甙乙酰转移酶(aac(6′)-Ic) | an 01 | 5′AGCAACAGGGGTGCAGCGAGCTGGCGTCGGATA3′ | 5′ACTACTCGCTCCGTTTCG3′ |
氨基糖甙乙酰转移酶(aacA4) | an 02 | 5′ATGACCTTGCGATGCTCTATGAGTGGCTAAAT3′ | 5′TCGGGCGTGCTTCTTCTC3′ |
氨基糖甙乙酰转移酶 | an 03 | 5′AACCTTTGTTTCGGTCTGCTAATAAATAACTCCT3′ | 5′TAAGCCTATCCAGCCAAC3′ |
β-内酰胺酶(ear) | am 01 | 5′AACAACAGTAGGTTCAGGTTTTCATTCTTCTTCAA3′ | 5′TTCCACAACTGTCCGTCT3′ |
低亲和性青霉素结合蛋白PbP5 | am 02 | 5′TGATACTGGATATGGACAGGGCGAACTTCTA3′ | 5′TGCTGTTTCGCCGATGAC3′ |
β-内酰胺酶/ampC | am 03 | 5′CGCCAGCAGTGTAGGTTGCGAGATGTAATAGTGT3′ | 5′CGCTAAACAGTGGAATGG3′ |
β-内酰胺酶(ampC)5′ | am 04 | 5′ACGCCCGTAAATGTTTTGCTGACCGAACCTAA3′ | 5′CCGCCTCTTGCTCCACA3′ |
链球脓菌M蛋白(emm) emm14.1allele | azt 01 | 5′CTTTCTGGCGTGCTTCTGATTGTTCTTG3′ | 5′CTGTTGATTAGGACGGGG3′ |
红霉素、竹桃霉素、阿奇霉素、霉素素、米卡霉素B结构抗性蛋白(msrSA) | azt 02 | 5′GAATCTGGAACAGTTGAAACGAATGGCGAA3′ | 5′CACTCATACTGTCGGTTGT3′ |
β-内酰胺酶,bla(SHV-2a) | tax 01 | 5′ACCCGCCTTGACCGCTGGGAAACGGAACTGA3′ | 5′GCCTCATTCAGTTCCGTTT3′ |
β-内酰胺酶(cfxA) | fox 01 | 5′TTATGGTCAGCCGACATTTCCTCTTCCG3′ | 5′GCTTGTCCTGGCGAAAT3′ |
LAT-2 b-内酰胺酶(bla LAT-2) | fox 02 | 5′GCGGCCAGTTCAGCATCTCCCAGCCTAATTTGC3′ | 5′GAAGCCTATGGCGTGAA3′ |
SHV型广谱β-内酰 | taz 01 | 5′GCACCCCGCTCGCCAGCT | 5′ACGGAACTGAA |
胺酶;kp386 | CCGGTCTTATCG3′ | TGAGGCG3′ | |
β-内酰胺酶CEF-1前体(blaCEF-1) | taz 02 | 5′TATCTATCTCAGACAAAACGGCTAAAGCAATCGG3′ | 5′ATGCCAGAATAGGAGTAGC3′ |
DNA旋转酶B亚基,GyrB(gyrB) | cip 01 | 5′GACGCTTACGCACGGCATCCAGCCCTTT3′ | 5′GTATCAAGGTATTAAAAGGGC3′ |
旋转酶A(gyrA) | cip 02 | 5′GCGAGAATCGTTGGGGATGTTATGGGGA3′ | 5′CGCAGCAGCACCATCA3′ |
旋转酶A(gyrA) | cip 03 | 5′GGTTTATCGGGCGTCATACCTTGTTCATTTA3′ | 5′CCAGTGAAATGCGTGAATC3′ |
DNA旋转酶A亚基(gyrA) | cip 04 | 5′ACGTTGAGCGGCAGCACTATCTCCATCC3′ | 5′TCCGTATGGCTCAATGG3′ |
氯洁霉素抗性决定基(ermFS) | cc 01 | 5′CAGGGCTGATTTGACAGTTGGCGGTGGC3′ | 5′CTGGGAGGTTCCATTGTC3′ |
rRNA N-6-甲基转移酶(ermM) | e 01 | 5′TTCGTAACTGCCATTGAAATAGACCATAAA3′ | 5′AGCAAACCCGTATTCCAC3′ |
rRNA甲基化酶(ERM-TE) | e 02 | 5′TCTGGAACATCTGTGGTATGGCGGGTAA3′ | 5′AAAACTTACCCGCCATAC3′ |
rRNA甲基化酶(erm) | e 03 | 5′AAAACTTACCCGCCATACCACAGATGTTCCAGAT3′ | 5′TGGCGTGTTTCATTGCTTG3′ |
红霉素酯酶(ereA2) | e 04 | 5′TGTCGGCATTGGCGAGGGTGCTCACTTTG3′ | 5′TCAAGGTGTTGGGTAAATC3′ |
红霉素抗性蛋白(ermA) | e 05 | 5′CCGTCCACCGTCCGTAGTCACCCGTCCGCTT3′ | 5′CCCGAGGAGCCGTTCCAGTT3′ |
红霉素诱导的23S核糖体RNA甲基化酶(ermK) | e 06 | 5′CCAAAAGTGGACTCGGCAATGGTCAGAATAACA3′ | 5′AATGTTTATGTGATAGAGGC3′ |
红霉素甲基转移酶(AA1-253) | e 07 | 5′CAATGACGCAGGGAGTGGCGGGTAACCGGAAG3′ | 5′ATCGGACCAGGAAGCG3′ |
大环内脂-林可酰胺-密柑霉素B抗性 | e 08 | 5′CTAAGACGCAATCTACACTAGGCATGGGATGGAAG3′ | 5′CGCAAAAAGATTTATGGG3′ |
23S rRNA甲基化酶(ermQ) | |||
大环内脂2′-磷酸转移酶I(mphA) | e 09 | 5′GACCGTAGTCACGACCGCCGATACCTCCCAAC3′ | 5′GCCCAAGCTCATTGACAG3′ |
Mrx | e 10 | 5′ACGCGGCACCGAGCACCACGCAAGCGATCAGC3′ | 5′CGCATTGATCTCGGGTGT3′ |
阅读框B mls抗性 | e 16 | 5′AATCGTGGAATACGGGTTTGCTAAAAGATTAT3′ | 5′AGTAATGCCAATGAGCG3′ |
N-6-氨基腺嘌呤-N-甲基转移酶(NMT) | e 11 | 5′CGGCGGCAACATCCAGGCGTCGCTTCTGCG3′ | 5′CCTCGGTTCGTTCTTCTTG3′ |
红霉素抗性蛋白(msrA) | e 12 | 5′GAATCTGGAACAGTTGAAACGAATGGCGAA3′ | 5′CCACTCATACTGTCGGTTGT3′ |
红霉素抗性甲基化酶(ermTR) | e 13 | 5′CAATACAGAATCTACATTAGGCTTAGGGTGAA3′ | 5′AGTCAACGGGTGAATGCT3′ |
21kDa MsrB C末端产物(msrB) | e 14 | 5′GATAATTTCGTTCTTTCCCCACCACTCA3′ | 5′CTTGAGCGTTCTTGTAATG3′ |
rRNA甲基转移酶 | e 15 | 5′CAGGGAAAGGTCATTTTACTGCTGAATTGGTA3′ | 5′GTAAGGTATGCTGCCAAA3′ |
UDP-N-乙酰半乳糖苷烯醇丙酮酰转移酶(murA) | fos 01 | 5′GCCCCGGCACGGATGTCCGAACACCACA3′ | 5′GATGGCTATCGCTTTGGC3′ |
磷酸转移酶(fosC) | fos 02 | 5′CGAAGTCCGCAGCGAGCAACGGGGCGATAT3′ | 5′CGGGTCTATCCCTTTCA3′ |
fosB基因 | fos 03 | 5′GAGATATTTTAGGGGCTGACATTTTAGTTGAA3′ | 5′TCTTCGTTCAAAGCCAACC3′ |
fosB基因 | fos 04 | 5′TCAGATAACGATTTTGAAGATTGGTATAACTGGTTG3′ | 5′CTTCTAAACTTCCTGTATGC3′ |
氨基糖甙修饰酶(aph(2″)-Id) | gm 01 | 5′ACTTAGAAATCGGCCAGGTCCTTAGCT3′ | 5′TCAATAATCTGCCGAAGC3′ |
氨基糖甙-(3)-N-乙 | gm 02 | 5′CGCCGTACCTGGCCGCCG | 5′CTCCGTCAGCG |
酰基转移酶同功酶II (AAC(3)-II),(aacC2) | TTCGATCCCG3′ | TTTCAG3′ | |
氨基糖甙腺苷转移酶(aadB,ant(2″)-Ia) | gm 03 | 5′CCTCCGCGATTTCATACGCTTCGTCTGCCC3′ | 5′TACTTGACTGCGAACCTG3′ |
庆大霉素抗性蛋白 | gm 04 | 5′GTGATGGAAATCCCTTCGTGGGCTACCG3′ | 5′CATCCCGTCTTCACCC3′ |
庆大霉素抗性(aadB) | gm 05 | 5′TGGGCAGACGAAGCGTATGAAATCGCGGAGGC3′ | 5′GACCTGAAAGCGGCAC3′ |
庆大霉素抗性(aadB) | gm 06 | 5′CGCAGCAGGCAGTCGCCCTAAAACAA3′ | 5′TTTGTTTTAGGGCGACT3′ |
抗庆大霉素甲基化酶(grm) | gm 07 | 5′GCCAGCGGATTGAGGCCACGGCGAGGT3′ | 5′GATCTTCCGTCACGTGC3′ |
庆大霉素乙酰转移酶(aacC1) | gm 10 | 5′CTCGGGAACTTGCTCCGTAGTAAGACATTCATCGC3′ | 5′ATCACATAAGCACCAAGC3′ |
S-腺苷,甲硫氨酸依赖性甲基化酶(kgmB) | gm 08 | 5′CGTGACGCTGCTGCTCAAGACCGTGCCC3′ | 5′CTTCGTCGGGAAACTCAC3′ |
aacA-aphD氨基糖甙抗性基因 | gm 11 | 5′AAATAATCCAAGAGCAATAAGGGCATACCAAAA3′ | 5′CACTATCATAACCACTACCG3′ |
庆大霉素乙酰转移酶-3-I(AAC(3)-I) | gm 09 | 5′TCTCGCGGCTTACGTTCTGCCCAGGTTTG3′ | 5′ATCACATAAGCACCAAGC3′ |
β-内酰胺酶oxa-23(ari-1) | imi 01 | 5′AAAATGTTGAATGCCCTGATCGGATTGGAG3′ | 5′CCTGATAGACTGGGACTGC3′ |
β-内酰胺酶ACT-1 | imi 02 | 5′TGCCACGTAGCTGCCAAACCCGCCGGTAGAG3′ | 5′GAGAAGTGAATCCACCAGC3′ |
广谱β-内酰胺酶(blaESP) | imi 03 | 5′TTCATAGCGACAGCACGGGCGGAATAGA3′ | 5′GCTTGAACCTTACCGTCT3′ |
卡那霉素抗性多肽 | k 01 | 5′TCCCGTGCGAGCAGATCCATCAGCAGTCCG3′ | 5′AAGGACGGACTGCTGATG3′ |
氨基糖甙修饰酶(ant2) | k 02 | 5′CCTCCGCGATTTCATACGCTTCGTCTGCCC3′ | 5′TACTTGACTGCGAACCTG3′ |
氨基糖甙磷酸转移酶(aphA1-IAB) | k 03 | 5′GCGATTCCGACTCGTCCAACATCAATACAACC3′ | 5′GTATTTCGTCTCGCTCAG3′ |
卡那霉素核苷酰转移酶(aa1-253) | k 11 | 5′AAGTGTATCAAACTGCTAAATCGGTAGAAGCCCAA3′ | 5′AAATGTTGTCGGTCCTTGC3′ |
3′-氨基糖甙磷酸转移酶[APH(3;)-I] | k 04 | 5′CGGTCTGCGATTCCGACTCGTCCAACAT3′ | 5′AATGAATAACGGTTTGGT3′ |
卡那霉素磷酸转移酶(aphA-7) | k 12 | 5′TCTTCTTGAGGTTGATTTTCGCAAAGCCACTGATA3′ | 5′TAAACGCACTTCATCAGC3′ |
新霉素磷酸转移酶(抗新霉素和卡那霉素) | k 13 | 5′GCGGGAAGGGACTGGCTGCTATTGGGCG3′ | 5′GCAGGAGCAAGGTGAGA3′ |
卡那霉素磷酸转移酶(KM-R) | k 05 | 5′AGGAATCGAATGCAACCGGCGCAGGAAC3′ | 5′TTCCGACCATCAAGCA3′ |
氨基糖甙磷酸转移酶(aph) | k 06 | 5′TGTATGGGAAGCCCGATGCGCCAGAGTT3′ | 5′CCGTCAGCCAGTTTAGTC3′ |
氨基糖甙磷酸转移酶aph(3′)-Id(aphA) | k 14 | 5′TCGCATCCCATACCTGCTCAGCCGCCCAGCCTTT3′ | 5′GAATGCCCTTTCAACAG3′ |
PP-KAN 蛋白(pp-kan) | k 07 | 5′GCGATTCCGACTCGTCCAACATCAATACAACC3′ | 5′GTAATGGCTGGCCTGTTG3′ |
S-腺苷甲硫氨酸依赖性甲基化酶(kgmB) | k 15 | 5′CCGACGTGACGCTGCTGCTCAAGACCGTGCCCT3′ | 5′TCGTCGGGAAACTCACC3′ |
3′5′-氨基糖甙磷酸转移酶(aphA-3) | k 16 | 5′AATGTCATACCACTTGTCCGCCCTGCCGCTTCT3′ | 5′AAAGCCCGAAGAGGAACT3′ |
抗卡那霉素-阿泊拉霉素甲基化酶(KAMC) | k 08 | 5′CGGAGTTCCTGATCACGCTCAACCTGCACGCCT3′ | 5′GCGTAGTACGGGGCGAG3′ |
抗卡那霉素-阿泊拉 | k 09 | 5′AGCTGCGGTTGCACTCGA | 5′CCTGCCCAACC |
霉素甲基化酶(KAMB) | CCAGGAAGGAC3′ | TGCTGT3′ | |
卡那霉素抗性基因 | k 10 | 5′TGTATGGGAAGCCCGATGCGCCAGAGTT3′ | 5′CCGTCAGCCAGTTTAGTC3′ |
青霉素结合蛋白1A(pbp1a) | pen 01 | 5′TTTGATTGTTGCGTATTATTGTTAGGTTGGT3′ | 5′CTCACCTGCTCCACAACAAC3′ |
青霉素结合蛋白(pbp1a) | pen 02 | 5′AACGGGTCGTGGTGCTTATCTCCCTTGGCTAC3′ | 5′AGAAGCCATCACCAACGA3′ |
青霉素结合蛋白1A(ponA) | pen 03 | 5′AAGATAGGCTCCACGCCCAGTTCCAIAAGT3′ | 5′CTCIAATGTCGGAACTCG3′ |
青霉素结合蛋白1A(ponA) | pen 18 | 5′AGATGGCTGCTGCTTACGCTGCCTTTG3′ | 5′CTCCCATCACTAAAGACG3′ |
青霉素结合蛋白1A(ponA) | pen 04 | 5′TCATTCGGCACCAACCAGGCTGTGGAGACC3′ | 5′AAAGCGGGAGCATAGTCA3′ |
低亲和性青霉素结合蛋白PbP5(pbP5) | pen 05 | 5′CAATAGTTCCGATGCTCGTTTGGTTGCTGA3′ | 5′CTTTAGGGATTCCGTTGG3′ |
青霉素结合蛋白5 | pen 19 | 5′TCAGTAATCAAGTGATCCGCAAGAACCGCCATAT3′ | 5′ATCTTCACGGGCATCAGC3′ |
青霉素结合蛋白1B(ponB) | pen 06 | 5′AAATGACGGTCTTCTGTCGCCAGCAAAGTATCCAC3′ | 5′GAGCAGCGTCTGTTTGTG3′ |
β-内酰胺酶(ampC) | pen 07 | 5′GCCGCCAGCAGTGTAGGTTGCGAGATGTAA3′ | 5′CGCTAAACAGTGGAATGG3′ |
青霉素结合蛋白3r(pbp3r) | pen 20 | 5′ATTGTAATAGTTCGGGTGCTCGTTTAGTTGCTGA3′ | 5′TCTTTCTGCTTTAGGGATT3′ |
青霉素结合蛋白2(penA) | pen 21 | 5′CGCATCCAGTGCTTTCGCAATGACAAACGGCT3′ | 5′AGACAGCGAACAGAGGCG3′ |
青霉素结合蛋白2(penA) | pen 08 | 5′CGCCGTAATAGCCGTTGGCAGTCGGTTCGT3′ | 5′AGTGCGTGAGTTGATGG3′ |
青霉素结合蛋白2(penA) | pen 22 | 5′TTTGACGGCTGCGGCGGTCAGTGGCTTGGTCGGG3′ | 5 ′CTGCCCACGGCTATTACG3′ |
青霉素结合蛋白2(penA) | pen 23 | 5′TTGTGCGGCAGACGGCATTTCCTTCATC3′ | 5′AAGAACAGGGCGACAACC3′ |
青霉素结合蛋白2(penA),only has the3′-half of others | pen 24 | 5′TGGGCGGCAGCCTGAACATCTTGGGCGTTT3′ | 5′TTAAGACGGTGTTTTGACGG3′ |
青霉素结合蛋白4(pbp4) | pen 09 | 5′CTTTGTTATTCATTAAATCAACGAAATCGCTGGTG3′ | 5′GGACAATCGCAGACCTAT3′ |
青霉素结合蛋白2(pbp2) | pen 10 | 5′AAACTTGGCTTAAACTACGAAGGCGATATTGGTCC3′ | 5′GTTTCGCCGTCACGAGTA3′ |
低分子量青霉素结合蛋白 B(pcbR) | pen 11 | 5′ATCTCCGTCTTCGTCGGCTTGAGGTTGGTC3′ | 5′GGACAACGCCGAGTCGCTGA3′ |
青霉素钝化蛋白及抗抑制因子(mecR1) | pen 25 | 5′TTTCGCCATTCGCATTGTCTTCGCCTTTTA3′ | 5′GCAAATGGATGGTTCGTAGG3′ |
青霉素结合蛋白2x(pbp2x) | pen 12 | 5 ′CAGAACTGGTATCGCAACAAACTGTGGATGGCAAG3′ | 5′GTAGGTCGTTGGGTGGTA3′ |
青霉素结合蛋白2b(pbp2b) | pen 13 | 5 ′CTTCTGCTTCTTCCGCTGGGAGACCGGCTTT3′ | 5′AGTAGGGAGTGTATCCAGTG3′ |
青霉素结合蛋白1a(pbp1a) | pen 14 | 5′GTTACAGCAGTTGAAACGCTTGAAAGGGTCGGA3′ | 5′GAAATAGCGTTAGCATAGAC3′ |
青霉素结合蛋白2b(pbp2b) | pen 15 | 5′GGAGCCAAGTATTCAGAAGGTGTGTATGCAGTCGC 3′ | 5′AGACATTGGTTACTGTTCCC3′ |
青霉素结合蛋白1b(pbp1b) | pen 16 | 5′GAAGCAATCACCGTCCCGTCCGAATAGGTAATCTC3′ | 5TTGACAAGGTTCGGGTGC3′ |
青霉素结合蛋白1b(pbp1b) | pen 26 | 5′ACTGATCGTATTCTTCCTGAGTCAGAGCACCCGTA3′ | 5′CCCCAGAGTCCGATTA3′ |
青霉素结合蛋白2a(pbp2a) | pen 17 | 5′TCAGCAACTTGACCGACAACTCCACGAACTCCCC3′ | 5′CTATTTCCGAGGGCAGAG3′ |
链霉素磷酸转移酶(strA) | st 01 | 5′GCTGATCGGCCTGCGAGCCTGGGGCGGGGAC3′ | 5′AGGCGTTCCAGCAGCATC3′ |
链霉素抗性蛋白A(strA) | st 14 | 5′GGCGTACTCTTGTCCTCGTCCGGTAAGAAGTCG3′ | 5′GCCGTTGATGTGGTGTCC3′ |
链霉素抗性蛋白B(strB) | st 02 | 5′CCCGTCGGTCTGGTCGGTGAAGTGGGCTTTGGC3′ | 5′AGTCGTCCGCCATCTGTG3′ |
链霉素磷酸转移酶(strA) | st 15 | 5′CCGTCACCACGTCGAAAAACAAAATCACCAG3′ | 5′TCGCATTCTGACTGGTTG3′ |
链霉素和大观霉素抗性氨基糖甙腺苷转移酶(aadA5) | st 03 | 5′CGTTCCGCTCGTCACCCTTCCAATCCGACTCTGC3′ | 5′GCCACGACATCCTTTCC3′ |
链霉素抗性蛋白(aadA2) | st 04 | 5′CGCCAGGGAAAGCCGAAGCCTCCATAAGGTCAT3′ | 5′TTTGTTGGTTACTGTGGC3′ |
腺苷转移酶(aadA4) | st 05 | 5′TCAGAGTCGGATTGGAAGGGTGACGAGCGG3′ | 5′TTAGGAGCAATGAGACCC3′ |
氨基糖甙磷酸转移酶(aph) | st 16 | 5′CGGAAGTACCCGCACCACGAGTGGCACGCAG3′ | 5′CCGAGTCTCCTTCGTTCA3′ |
氨基糖甙腺苷转移酶A(aadA2) | st 06 | 5′AATGACCTTATGGAGGCTTCGGCTTTCCCTGGCG3′ | 5′GATAACGCCACGGGATG3′ |
链霉素磷酸转移酶 | st 07 | 5′TCCGGGGCCGGGGACCTTGCACAGATAGCGTG3′ | 5′AAGCCTCGTCGTCTG3′ |
链霉素抗性(strA) | st 08 | 5′ACATACACCACGTTTCTGCGGGCAAGCCTCTAA3′ | 5′GGCAACTATCAACCAGC3′ |
链霉素腺苷化酶(str) | st 09 | 5′ATTCCCACCTGATTTAGATTATGGTTACAGTTAT3′ | 5′ACACTCCAAAACTCATTACAGC3′ |
aadA基因产物(AA188-236) | st 10 | 5′TCCCGCATTTGGTACAGCGCAGTAACCGGCAGA3′ | 5′AGTACGGGCTGATACTGG3′ |
str | st 11 | 5′AAAACACCCTTTGCTACATACGTTGAGACACT3′ | 5′ATTGCTGTAATGAGTTTTGG3′ |
氨基糖甙磷酸转移酶(aph(6)) | st 12 | 5 ′CGCCTCAAAGACATCGCCGCCGACATGCTGGA3′ | 5′CCCAGCCACGCAACAACT3′ |
氨基糖甙磷酸转移 | st 13 | 5′CTCTGCCTGCCCAACATC | 5′GATGAAGCCCG |
酶(aphE) | GTCCTCCATCCG3′ | ACACCTC3′ | |
链霉素磷酸转移酶 | st 17 | 5′GCCCTTCGGCGGGTTGAGCCTGATGCCCTGGTC3′ | 5′CAACACCGTCTGTCTGC3′ |
磺胺抗性蛋白(sulA) | sul 01 | 5′ATAGCCCTTCTGATGTAGTTTATCCAGGTCCCGT3′ | 5′TCTGACCAAGAAAGAAAATC3′ |
磺胺抗性基因 | sul 02 | 5′AGTCGGCGTTGGGGCTTCCGCTATTGGTCTCG3′ | 5′GACGTAGTCAGCGCCATTGC3′ |
磺胺抗性蛋白(sulII) | sul 03 | 5′AAACGCAACCGCCTTGTCCTTGATCCCGGCATGG3′ | 5′AGAGCGAGGTTTCGGGAG3′ |
二氢叶酸合成酶(folP) | sul 04 | 5′AAGTATTTTAGATGTAGGTATTGGTTTTGGAAAGAGT3′ | 5′AATGCAAATACAAAGTCCC3′ |
二氢叶酸合成酶(dhps) | sul 05 | 5′ACATCCAAACCAGAAGTCATCCGTGAGTCAGCGAA3′ | 5′CAGGTTCGGAAAGGGAGC3′ |
二氢叶酸合成酶(dhps) | sul 06 | 5′GATGTTGTCGGTGAAGTGGCGCGGTATTTGAAAGC3′ | 5′GTTTCCGCCATCAATTCGGG3′ |
二氢叶酸合成酶(dhps) | sul 07 | 5′TCCGCCATCAATTCGGGTAAATGCCGCATCAGT3′ | 5′GGATGTTGTCGGTGAAGT3′ |
PP-SUL | sul-08 | 5′CATTCCCGTCTCGCTCGACAGTTATCAACCCGC3′ | 5′TCTGCCTGCCCGTCTTG3′ |
S1二氢叶酸还原酶(DfrA) | tmp 01 | 5′TGTCGCTCACGATAAACAAAGAGTCATTGGGTAC3′ | 5′TTTCCGTGCCATTACAAG3′ |
二氢叶酸还原酶(dfr)(抗三甲氧苄二氨嘧啶) | tmp 02 | 5′TTAGACTTCCTTTCTCTTGCGGTATTGGATGGT3′ | 5′ATTCATGCTCGGGTGGA3′ |
抗三甲氧苄二氨嘧啶二氢叶酸还原酶dhfrXVI | tmp 03 | 5 ′CCCAAATCGAAAGTATGCAGTTGTAACTCGCTCTA3′ | 5′ATTACACCCTCATCATTCG3′ |
二氢叶酸还原酶(抗三甲氧苄二氨嘧啶)(dfr17) | tmp 04 | 5′CATATTTGCGATTTGGAAGAACACCCATAGAGTC3′ | 5′TCAATGGCTCCTTGTCGG3′ |
VIII型二氢叶酸还原酶(dhfrVIII) | tmp 05 | 5′GCGACTGTACGAAGGCGACACCTACGTTGATC3′ | 5′GCCATTCTGCTCGTAGTC3′ |
Ib型二氢叶酸还原酶(dhfrIb) | tmp 06 | 5′AAACGGCGTGATTGGTTGCGGTCCAGACATAC3′ | 5′CGCCCATAGATTCAAACG3′ |
VIII型二氢叶酸还原酶(dhfrVII) | tmp 07 | 5′TGCAACGTCAGAAAATGGCGTAATCGGTAATGG3′ | 5′TGGAAGAACACCCATAGAG3′ |
二氢叶酸还原酶(dfr2a)(抗三甲氧苄二氨嘧啶) | tmp 08 | 5′GCCGCCTGGCAAGGTCAGATTGTCGGGTGGTA3′ | 5′TACTGAGCCTGGGTGAGC3′ |
二氢叶酸还原酶 | tmp 09 | 5′CTGGGTGGGATTCGGACTCGACCGCATAGCC3′ | 5′GTCGTCGGTTGGTATTGC3′ |
二氢叶酸还原酶 | tmp 10 | 5′TCGGATGCCAAAGCGATAGCGTGCGACAGCG3′ | 5′GCAAGCCTCTACCGAACC3′ |
二氢叶酸还原酶(dhfrIX) | tmp 11 | 5′GTAGTCAGTAAAACAGTACCACCCACCCAGAACA3′ | 5′TACGCACTCTTCCCACCA3′ |
二氢叶酸还原酶(dfrXIII) | tmp 12 | 5 ′CCTTTGAGGGTGACGCCTTCTTCCCAGTGCTTA3′ | 5′CTTGAATGGTTTCGGATG3′ |
二氢叶酸还原酶(folH) | tmp 13 | 5′TTCAAAGGTTTTACGCCCCATAATGACAGGTT3′ | 5′GTTTCGTCAGAACACCACT3′ |
二氢叶酸还原酶DHFR L1(dfrD) | tmp 14 | 5′ATGGAATGTCGTTATCCTTGCCGATTACTCTTT3′ | 5′ATTGTTGCGATGGATAAG3′ |
S1 DHFR | tmp 15 | 5′TGTCGCTCACGATAAACAAAGAGTCATTGGGTAC3′ | 5′AATCATTTGGTAAGTGCC3′ |
I型3′-氨基糖甙磷酸转移酶(aphA1) | tob 1 | 5′CAACGGGAAACGTCTTGCTCGAGGCCGCGATTAAA3′ | 5′CGATAGATTGTCGCACCT3′ |
FirA | rif 1 | 5′TGCCCGTAACCGTCACTTTGTCGCATTTTCCAT3′ | 5′TTGGCGACAATACGGC3′ |
RNA聚合酶β亚基(点突变) | rif 2 | 5′ACAGCGGGTTGTTCTGGTCCATGAATTGGCT3′ | 5′GGAGTTCTTCGGCACCAG3′ |
利福平抗性(firA) | rif 3 | 5′CTATTCTAGCGTTTCTGCC | 5′TGAAATCCGCTA |
GATATTTACTCCTC3′ | TTGTTG3′ | ||
RNA聚合酶β亚基(rpoB) | rif 4 | 5′TTCAACACGACCTCTGTGCTTAGCTGTAATAGCCG3′ | 5′TTTCAGCAGCGACAGCA3′ |
RNA聚合酶β亚基(rpoB) | rif 5 | 5′AGAAAGGAATACATGCTGTCGCAACGGCAACTACC3′ | 5′TGGGACGTCACCAAGGGG3′ |
膜结构蛋白(ptr) | rif 6 | 5′CGGAGTCCAAGAACCCGCAGGGCGACAGGC3′ | 5′TGGTTACGGAAGAAGTGC3′ |
甲苯异恶唑青霉素酶(oxa9) | oxs 1 | 5′GCCCACGAACCAGCCCTGCGGACGACTTTCATTT3′ | 5′GGCGTATGCCACAATCCC3′ |
ABC转运因子TetB(tetB) | oxs 2 | 5′ACCTGGCCGATGCCTGTGAGCCGGATGAAC3′ | 5′GTCCGCTTCGCCTTGAT3′ |
ABC转运因子TetA(tetA) | oxs 3 | 5 ′CGTGAGCATCAAGCCGTTCGCCTTCGCCGTTTC3′ | 5′GGATGTCGCTGGCTTGG3′ |
甲苯异恶唑青霉素水解酶(oxa2) | oxs 4 | 5′ATCGTAACGAGCTGCCCTTTCGGGTAGAACATC3′ | 5′CTTCCCAGCCCGTCTTTG3′ |
DNA旋转酶(gyrB) | na 1 | 5 ′CCGCAAAGGGCTGATGGACGGCTTGGGACTG3′ | 5′TGCGGTGGTAGCGTAGTTT3′ |
C类β-内酰胺酶(ampC) | fep 1 | 5′AGCCGCTCAAGCTGGACCATACCTGGATTA3′ | 5′CGCCTCTTCCGCTTTCG3′ |
β-内酰胺酶(bla) | zox 1 | 5′GTTTCGTCTGGATCGCACTGAACCTACGCTGAATA3′ | 5′TCGTATTGCCTTTGAGCC3′ |
β-内酰胺酶SHV-13(bla) | ctr 1 | 5′TCATTCAGTTCCGTTTCCCAGCGGTCAAGGCG3′ | 5′TGACGGTCGGCGAACTCT3′ |
β-内酰胺酶(cumA) | roxh 1 | 5′AATCCGACTTAGTTGCTTACAGCCCTATTACAGAA3′ | 5′TTGAGTGACTTTGGCTGGA3′ |
β-内酰胺酶(blaB) | roxh 2 | 5′ATCGCAAAGCGTTCTTCACCACGGTATGTTATT3′ | 5′CCAATGCTATGGGCTGAC3′ |
β-内酰胺酶(blaIRT-14) | ca 1 | 5′GAATAGTGTATGCGGCGACCGAGTTGCTCTTGC3′ | 5′TTCTGCTATGTGGTGCGG3′ |
延长因子G(EF-G) | fa 1 | 5′GCAGCAGATGTGATAGTA | 5′ATGGACTGGAT |
(fus) | ATACCACGGTCTTGTTC3′ | GGAGCAA3′ | |
酯酶(fusH) | fa 2 | 5′GCGACCCTGGGCGGCAAGACCCTCGGCAT3′ | 5′GTGGTGACGGGTTCGGC3′ |
阅读框 | fa 3 | 5′TCATCAGGCGGGCAAGAATGTGAATAAAGG3′ | 5′ATAACCAGACCGTTCAGC3′ |
普那霉素抗性蛋白(VgaB) | pri 1 | 5′GGATAAAATAGGTATTGTAGGTAAGAATGGAGTTGGC3′ | 5′ATCTTGAAATCCCTCTGC3′ |
抗抑制因子的β-内酰胺酶TEM-77(blaTEM-77) | amc 1 | 5′AATAGTGTATGCGGCGACCGAGTTGCTCTTGC3′ | 5′GCACGAGTGGGTTACATC3′ |
连接酶(vanE) | va 1 | 5′CGTTTCCCAACACGGCACAGCCAACTTCA3′ | 5′GACGCCGCCATTGAAACA3′ |
D-α-D-α肽酶(vanXst) | va 2 | 5′CGTGATGGAGTCCTGCGGTTTCAAGGCGTA3′ | 5′TCGGCGAGCGTGTAGTG3′ |
D-乳酸脱氢酶(vanH) | va 3 | 5′GCTCATCAGTCCGCATACCGCCTATTACAC3′ | 5′TACTACTTCCCGCTTTCG3′ |
D-丙氨酰-D-丙氨酸连接酶(ddlN) | va 4 | 5′GAGCCGTACTACATCGGGATCACCCAGAGC3′ | 5′TCGCCGTTCTCCCAGTC3′ |
D-丙氨酰-D-丙氨酸二肽酶(vanx) | va 5 | 5′GGACCTGACGCTCTACCGCCTGGACACC3′ | 5′CACCACTCGCACTCGTAG3′ |
万古霉素抗性蛋白vanx) | va 6 | 5′TCGCATTGTAGGGACATACGAGTTGGCTGA3′ | 5′AACCGTCCCATAGAAGCA3′ |
D-丙氨酰-D-丙氨酸连接酶 | va 7 | 5′CGCTTGCGGCTCATCATTGCCCAGAACGCTCAC3′ | 5′TTGAAGCAGGCGATTGAG3′ |
VanS(vanSb);VanY(vanYb) | va 8 | 5′CTGGCTGGATTTACCGCTCACATCAACA3′ | 5′CTACGATTTGTGGCTGGT3′ |
D-丙氨酰-D-丙氨酸连接酶(vanD) | va 9 | 5′ACTGGGAAACGGAAATGATCTCATGGCTGGCG3′ | 5′TAAGGCGGCTGGAACTCG3′ |
D-α-D-α连接酶 | va 10 | 5′GCGGACGACCGAATAGG | 5′CGGCATCCCCT |
TGAGCGACTTG3′ | ACGTCGG3′ | ||
万古霉素抗性蛋白(vanC-3) | va 11 | 5 ′CGGTGTTGAGATCGGTTGCGGTATTTTGG3′ | 5′AGCACCGACAGTCAAAGA3′ |
D-Ala:D-Lac连接酶(vanB) | va 12 | 5′GCCAAAGGACGAACCTGACCGTGCCG3′ | 5′ATGGACAAATCACTGGC3′ |
万古霉素抗性蛋白(vanB) | va 13 | 5′TCCTGATGGATGCGGAAGATACCGTGGCTC3′ | 5′TTGATTGTCGGCGAAGTG3′ |
VANA连接酶(vanA) | va 14 | 5 ′CAATACCGCACAACCGACCTCACAGCCCGAAAC3′ | 5′TTCAGGCTCATCCTTCGG3′ |
VanR | va 16 | 5′CCCGAGCAATTAACTCCAGTGGGCGAAAGG3′ | 5′CGGGAAAGATACAGAGGT3′ |
万古霉素组氨酸蛋白激酶(vanS) | va 17 | 5′GACAATGCTCGTTCTTCCGATACGGGTGG3′ | 5′CAACCAAGTCTGGCATCG3′ |
万古霉素抗性蛋白(vanH) | va 18 | 5′TACCTTGCCACGGTCGCTGTCCAACCTGAA3′ | 5′GCCTCTATTCTTCTTGCG3′ |
D-丙氨酸-D-丙氨酸连接酶相关蛋白(vanC) | va 19 | 5′TTTGTTCATACATAATGCGGAGGCAGCGAC3′ | 5′GAAGTATGGCGAGGATGG3′ |
D-特异D-2-羟酸脱氢酶(ddh) | va 20 | 5′ACACGGCGTTCAATATCTGGGAAGCGACGCACTA3′ | 5′TCTGTTTCTATCGCCCTAC3′ |
D-丙氨酸-D-丙氨酸连接酶相关蛋白 | va 21 | 5′CTTGCCTATGCGGTCGTCAGGAACGCGGGAATC3′ | 5′GACGGTCCAGAAGTTCGG3′ |
四环素抗性蛋白(tetC) | tet 1 | 5′CCGTTGAGCACCGCCGCCGCAAGGAATG3′ | 5′GCTTGTTTCGGCGTGGGT3′ |
四环素抗性决定簇(tetV) | tet 2 | 5′CGCCCGCCCAGCCCGCCTCCGAGCACCAT3′ | 5′GTCCCAGCACGACGAGCACGAA3′ |
四环素抗性蛋白(tetAJ) | tet 3 | 5′GCTAATGATAACCGTGTTGCGTTCTCCCC3′ | 5′AAGTTCGTTTCGCTTGGC3′ |
药物泵出蛋白(TetA) | tet 4 | 5′GACTGGCGGCGGCGACATCGGGTTCCTC3′ | 5′CAAGGTAATCAAGCAGGGTA3′ |
四环素抗性蛋白(tetR) | tet 5 | 5′GCTGGTTTCGAGCGGCTGCGTTCATCTACAAC3′ | 5′TGTTGTAGATGAACGCAGCC3′ |
四环素抗性蛋白(TetG) | tet 6 | 5′CACATGCGATCTTCCAAGCGTTTGTTACCG3′ | 5′GAACACCATCCATCCCTGC3′ |
革兰氏阳性四环素泵出样蛋白(bct1) | tet 7 | 5′CTGGAGCAACTAATTTCGCCACCGCAATCATAC3′ | 5′GATTTTCGCAAGGTTAGTG3′ |
四环素抗性蛋白(tet) | tet 8 | 5′TCGATCCAATAAGACCAAATGCTTTACCCC3′ | 5′CTCGTAATGGTTGTAGTTGC3′ |
四环素抗性蛋白(TetW) | tet 9 | 5′GCAAAGCGGAAACAACCTCCAACTGCACCCG3′ | 5′CTGGACGCTCTTACGCAACT3′ |
tet基因 | tet 10 | 5′CGACAACCATCACAAGAGCTGGGAATGCGG3′ | 5′AGCCCGATTTATTCAAGG3′ |
TetBSR | tet11 | 5′AACCGCCTACAATCGCAATACCCGTTCCCTCTG3′ | 5′ATCAGAGGGAACGGGTATTG3′ |
TetQ蛋白 | tet 12 | 5′TGGATCAGCAATGTTCAATATCGGTATCAATGAGT3′ | 5′TTTTATGTCCTTTGGGGTCA3′ |
TetO | tet 13 | 5′GCTCTATGGACAACCCGACAGAAGCCCAGAAAGG3′ | 5′GGAGGCAGAAATAAAAGAGC3′ |
四环素抗性蛋白(tetA(p)) | tet 14 | 5′CCAATAAATGCTCCTATCTGCCCTGCTTGTGCTCCC3′ | 5′GTAGCACAGATTGTATGGGG5′ |
四环素抗性蛋白(tetB(p)) | tet 15 | 5′AGGTTGCCCTCATAGTTTCTAAATCCCATACCGCTT3′ | 5′CAGCCAGCACTCCAGCAGAT3′ |
四环素抗性蛋白(tetA) | tet 16 | 5′GTTGTTATAGAAGCCGCATAGATCGCCGTGAAG3′ | 5′GGCAGGTGGATGAGGAAC3′ |
四环素抗性蛋白(tetA) | tet 17 | 5′TAGAAGCCGCATAGATCGCCGTGAAGAGGA3′ | 5′CAGGCAGGTGGATGAGGA3′ |
E类tetA | tet 18 | 5′TCGCATAGGTCGTCGCCCTGTATTGTTACTTTCA3′ | 5′ACAACACCACACTACGCTG3′ |
四环素抗性决定簇tet(U)(orf1) | tet 19 | 5′CTGTCACATCCAACCCCAAAAGCCACGTATCCAAT3′ | 5′GCTGAGCCTTCTAATTGGTC3′ |
(ORF2) | tet 36 | 5′TTTTCGTCCAATAAGCTATGGTATCATTCAGTTTTCC3′ | 5′TAACCGTATTTCTAACAGCG3′ |
四环素抗性蛋白(tetM) | tet 20 | 5′TGTGTGACGAACTTTACCGAATCTGAACAATGGG3′ | 5′TTTCCGCAAAGTTCAGAC3′ |
四环素抗性蛋白(tetM) | tet 21 | 5′GCGTTGAGAAGCTGAGGTGGTATCGGCAA3′ | 5′CCCAGTGCTGTTGTTGTC3′ |
TetT(tetT) | tet 22 | 5′CATCTAACACTTTCAGAGTTCGCTCAACTTCGGCTA3′ | 5′CGGGCGTCTACAGTTTCA3′ |
四环素抗性(TetS) | tet 23 | 5′GTCATTCTCATTGGTGAAATTCCAGCCCGT3′ | 5′TGAATACAACGGGCTGGAA3′ |
tet | tet 24 | 5′TACAACGGGCTGGAATTTCACCAATGAGAATGACC3′ | 5′AGATTTCCGAATGCTTGCG3′ |
H类抗四环素泵出蛋白 | tet 25 | 5′ACAACTTCTATCGGTATGTCTTTGGCGGTTCTGG3′ | 5′CTGGTAAGATGACCCAAACG3′ |
pp-tetA | tet 26 | 5′CAGCAGCGCCCGGCGGAAACTCATTGCA3′ | 5′CTGGGAATAGAACAGCCGACAC3′ |
tetA(G)=TetA | tet 27 | 5′CGGCGGTGGCAGAATAGAGTGCTGTGAA3′ | 5′TCCCGATTCTGTTGCTGC3′ |
四环素抗性(tetK) | tet 28 | 5′ATAACTGTTTTAGTAAAAGATAATCCGCCCATAACAA3′ | 5′TGTAAATGTAGCGACAATAGGT3′ |
四环素抗性决定簇(tetB) | tet 29 | 5′CGATAGTTAGCAACGCAGCGATAAAGAAGGGGCAA3′ | 5′TGGTTCGGTTGGTTAGGG3′ |
四环素抗性蛋白(tet) | tet 30 | 5′TATTAGTTTGAGCTGTCTTGGTTCATTGATTGCTTTT3′ | 5′CCACCATAATCAGTGAAGGGA3′ |
杀菌抗性蛋白(qacA) | tet 31 | 5′CATGTAGCTGAAGAATCTGTAGTGGGCGCTGTCGA3′ | 5′GATGTTACAGCCTCGTTTGC3′ |
四环素抗性蛋白(tetL) | tet 32 | 5′TTAGCGTATTAAATGAAATGGTTTTGAACGTCTC3′ | 5′CAGTTTGTACTCGCAGGTGGT3′ |
四环素抗性蛋白 | tet 33 | 5′CCGAATGCCCGCCAACTC | 5′GGACCGACCGC |
CCGTGCCAGG3′ | TGAAGG3′ | ||
D类tetA | tet 34 | 5′TCCGCCCGAGATACAACATCCACAGCACAT3′ | 5′GCCGTTTGTCATTGCG3′ |
四环素抗性决定簇(tet347) | tet 35 | 5′CGGCAAGCTCATCGCGTCCTCGGGCCGGTTCA3′ | 5′GAGGTGATGACGGTCTGGGACA3′ |
拓扑异构酶IV(parC) | CIP-05 | 5′TGGCGGCGGAAGACCAACCACTCAGTCAGGAT3′ | 5′TGATGAGCCACCTGTTCG3′ |
A类β-内酰胺酶(bla IBC-1) | TAZ-03 | 5′CCTGCCACGGAGCGGTTTCTAGCATCGGG3′ | 5′GTGTTGTCGCCCATCTCC3′ |
青霉素结合蛋白(pcbR) | LAC-01 | 5′GACGCATTCCGACAACTATGGCGATGACCCG5 3′ | 5′GGTGTAACCCCAATAGCC3′ |
D类β-内酰胺酶(OXA-18) | LAC-02 | 5′TCGCAGCAGAAGCCGACCGATCCGACCAT3′ | 5′CTGCGAATACCAGACGAT3′ |
林可霉素抗性蛋白(lmrB) | LIN-01 | 5′AGCCATAATGCTGACCGCAACCGCTGTTCCGATA3′ | 5′AAATGTCACGACCACTTCA3′ |
林可霉素抗性蛋白(lmrB) | LIN-02 | 5′GAGATCCATCAGTGCTTTGTCTTGCTTGCCGAGTT3′ | 5′CGCCATCGCACTCCTCAT3′ |
林可霉素抗性基因(linAn2) | LIN-03 | 5′TAAATCGTAGCCCGAATGGAATACTTGTTGCC3′ | 5′GCGGACGGCACTTCCAAAC3′ |
林可霉素抗性蛋白(lmrA) | LIN-04 | 5′GGGATTGCGTGCGGTCGTCTCGTCCTTCTTG3′ | 5′AAGGCGTTGAGCGTCTGGC3′ |
林可霉素抗性蛋白(lmrB) | LIN-05 | 5′CGTCAAGGTCGTCGGCGAGGACATTCTGC3′ | 5′TGTGCGGAACGGTCGGAAGC3′ |
林可霉素抗性蛋白(lmrC) | LIN-06 | 5′ATCCATCAGTGCTTTGTCTTGCTTGCCGAGTT3′ | 5′CGCCATCGCACTCCTCAT3′ |
林可霉素抗性甲基化酶(lmrB) | LIN-07 | 5′AAGGCGAACCTCGGCACCCGCTTGAGCACC3′ | 5′TCACGGCGGAGTCCTGGC3′ |
林可霉素抗性甲基化酶(lrm) | LIN-08 | 5′GCCGACATCGTCGACTGGTGCCTGACCG3′ | 5′CGGTGCGTTTGCGGGCGTA3′ |
6′-N-乙酰基转移酶 | NET-0 | 5′GACTCTTCCGCCATCGCT | 5′AGCGACCGACT |
(AAC(6′)-II) | 1 | CTGGGCAGGTAGTGTTC3′ | CTTGATG3′ |
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 01120441 CN1246474C (zh) | 2001-07-13 | 2001-07-13 | 采用基因芯片技术检测耐药基因 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 01120441 CN1246474C (zh) | 2001-07-13 | 2001-07-13 | 采用基因芯片技术检测耐药基因 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1396271A true CN1396271A (zh) | 2003-02-12 |
CN1246474C CN1246474C (zh) | 2006-03-22 |
Family
ID=4664135
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 01120441 Expired - Fee Related CN1246474C (zh) | 2001-07-13 | 2001-07-13 | 采用基因芯片技术检测耐药基因 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1246474C (zh) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006012727A1 (en) * | 2004-08-02 | 2006-02-09 | Infectio Recherche Inc. | Capture probe design for efficient hybridisation |
CN1304599C (zh) * | 2004-10-21 | 2007-03-14 | 复旦大学附属华山医院 | 耐药菌检测芯片及其制备方法和应用方法 |
CN100465289C (zh) * | 2006-01-18 | 2009-03-04 | 博奥生物有限公司 | 革兰氏阴性细菌耐药基因检测方法及其专用芯片与试剂盒 |
CN102321763A (zh) * | 2011-09-19 | 2012-01-18 | 李越希 | 细菌耐药基因检测芯片及其应用 |
CN102766573A (zh) * | 2011-05-05 | 2012-11-07 | 辅英科技大学附设医院 | 基因群检测结构 |
CN103421906A (zh) * | 2013-08-23 | 2013-12-04 | 中国检验检疫科学研究院 | 检测金黄色葡萄球菌耐药性的组合物和方法 |
WO2014102761A3 (es) * | 2012-12-31 | 2015-03-12 | Fundación Para El Fomento De La Investigación Sanitaria Y Biomédica De La Communitat Valenciana | Cebadores para detección y tipificación de cepas bacterianas productoras de carbapenemasas, kit y método de detección |
CN104531877A (zh) * | 2014-12-31 | 2015-04-22 | 南京安阔医疗科技有限公司 | 一种细菌耐药性筛查pcr芯片 |
CN104561340A (zh) * | 2015-01-23 | 2015-04-29 | 杭州迪安医学检验中心有限公司 | 一种检测细菌氨基糖苷类耐药基因的引物及试剂盒 |
CN105420383A (zh) * | 2015-12-29 | 2016-03-23 | 国家海洋局第一海洋研究所 | 一种海洋细菌耐药基因检测芯片及其应用 |
CN108026581A (zh) * | 2015-06-19 | 2018-05-11 | 剑桥企业有限公司 | 感染性疾病的诊断与治疗 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106636426A (zh) * | 2017-01-13 | 2017-05-10 | 重庆威斯腾生物医药科技有限责任公司 | 一种糖肽类抗生素耐药基因检测试剂盒 |
-
2001
- 2001-07-13 CN CN 01120441 patent/CN1246474C/zh not_active Expired - Fee Related
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006012727A1 (en) * | 2004-08-02 | 2006-02-09 | Infectio Recherche Inc. | Capture probe design for efficient hybridisation |
CN1304599C (zh) * | 2004-10-21 | 2007-03-14 | 复旦大学附属华山医院 | 耐药菌检测芯片及其制备方法和应用方法 |
CN100465289C (zh) * | 2006-01-18 | 2009-03-04 | 博奥生物有限公司 | 革兰氏阴性细菌耐药基因检测方法及其专用芯片与试剂盒 |
CN102766573A (zh) * | 2011-05-05 | 2012-11-07 | 辅英科技大学附设医院 | 基因群检测结构 |
CN102321763A (zh) * | 2011-09-19 | 2012-01-18 | 李越希 | 细菌耐药基因检测芯片及其应用 |
WO2014102761A3 (es) * | 2012-12-31 | 2015-03-12 | Fundación Para El Fomento De La Investigación Sanitaria Y Biomédica De La Communitat Valenciana | Cebadores para detección y tipificación de cepas bacterianas productoras de carbapenemasas, kit y método de detección |
US9914980B2 (en) | 2012-12-31 | 2018-03-13 | Fundación Para El Fomento De La Investigación Sanitaria Y Biomédica De La Communitat Valenciana | Primers for the detection and typing of carbapenemase-producing bacterial strains, and detection method and kit |
CN103421906A (zh) * | 2013-08-23 | 2013-12-04 | 中国检验检疫科学研究院 | 检测金黄色葡萄球菌耐药性的组合物和方法 |
CN103421906B (zh) * | 2013-08-23 | 2015-03-25 | 中国检验检疫科学研究院 | 检测金黄色葡萄球菌耐药性的组合物和方法 |
CN104531877A (zh) * | 2014-12-31 | 2015-04-22 | 南京安阔医疗科技有限公司 | 一种细菌耐药性筛查pcr芯片 |
CN104561340A (zh) * | 2015-01-23 | 2015-04-29 | 杭州迪安医学检验中心有限公司 | 一种检测细菌氨基糖苷类耐药基因的引物及试剂盒 |
CN108026581A (zh) * | 2015-06-19 | 2018-05-11 | 剑桥企业有限公司 | 感染性疾病的诊断与治疗 |
CN105420383A (zh) * | 2015-12-29 | 2016-03-23 | 国家海洋局第一海洋研究所 | 一种海洋细菌耐药基因检测芯片及其应用 |
CN105420383B (zh) * | 2015-12-29 | 2019-01-18 | 国家海洋局第一海洋研究所 | 一种海洋细菌耐药基因检测芯片及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN1246474C (zh) | 2006-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1246474C (zh) | 采用基因芯片技术检测耐药基因 | |
EP3004386B1 (en) | Microbial markers and uses therefor | |
AU2017200433A1 (en) | Multivariate diagnostic assays and methods for using same | |
JP6994941B2 (ja) | アンチセンス抗細菌性化合物および方法 | |
Aoike et al. | Molecular characterization of extraintestinal Escherichia coli isolates in Japan: relationship between sequence types and mutation patterns of quinolone resistance-determining regions analyzed by pyrosequencing | |
Kivata et al. | Plasmid mediated penicillin and tetracycline resistance among Neisseria gonorrhoeae isolates from Kenya | |
Ma et al. | A NASBA on microgel-tethered molecular-beacon microarray for real-time microbial molecular diagnostics | |
Yu et al. | Emergence of quinupristin/dalfopristin resistance among livestock-associated Staphylococcus aureus ST9 clinical isolates | |
Leelaporn et al. | A novel structure of Tn4001-truncated element, type V, in clinical enterococcal isolates and multiplex PCR for detecting aminoglycoside resistance genes | |
Narasimhan et al. | Ribonucleotide reductase, a novel drug target for gonorrhea | |
Murugan et al. | Resistome and pathogenomics of multidrug resistant (MDR) Pseudomonas aeruginosa VRFPA03, VRFPA05 recovered from alkaline chemical keratitis and post-operative endophthalmitis patient | |
AU2005318890A1 (en) | Method and kit for the detection of a large number of genes related to antibiotic resistance in microorganisms | |
AU762314B2 (en) | Oligonucleotide probes for detecting enterobacteriaceae and quinolone-resistant enterobacteriaceae | |
Sidhu et al. | Persistence of multidrug-resistant Staphylococcus haemolyticus in an animal veterinary teaching hospital clinic | |
JP5716758B2 (ja) | 結核菌における薬剤感受性を検出するための試験片 | |
US20080199877A1 (en) | Oligonucleotide probes for detecting enterobacteriaceae and quinolone-resistant enterobacteriaceae | |
CN108642169B (zh) | 检测十种甲氧苄胺嘧啶类药物耐药基因方法及所用试剂盒 | |
CN1061098C (zh) | 抗微生物制剂及其筛选方法 | |
CN110079619B (zh) | 检测革兰氏阳性细菌中四种糖肽类药物耐药基因的特异性引物和探针组合及应用 | |
CN109182563B (zh) | 检测20种dfrA类甲氧苄胺嘧啶类药物耐药基因的方法及所用试剂盒 | |
CN108624674B (zh) | Krt73作为分子靶标在帕金森诊治中的应用 | |
CN107058534B (zh) | 一种肝癌的生物标记物ensg00000248884及其应用 | |
WO2007129598A1 (ja) | グルタチオン増加物質のスクリーニング方法 | |
RU2636457C2 (ru) | ОЛИГОНУКЛЕОТИДНЫЙ БИОЧИП ДЛЯ ИДЕНТИФИКАЦИИ ГЕНЕТИЧЕСКИХ ДЕТЕРМИНАНТ РЕЗИСТЕНТНОСТИ Neisseria gonorrhoeae К АНТИМИКРОБНЫМ ПРЕПАРАТАМ, НАБОР ОЛИГОНУКЛЕОТИДОВ, ИСПОЛЬЗУЕМЫХ ДЛЯ ИММОБИЛИЗАЦИИ НА БИОЧИПЕ | |
US20040009574A1 (en) | Compositions and methods for detecting streptococcus agalactiae capsular polysaccharide synthesis genes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
ASS | Succession or assignment of patent right |
Owner name: LIU YUAN Free format text: FORMER OWNER: BEIJING SANXIONG HIGH-TECH DEVELOPMENT CO., LTD. Effective date: 20040730 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20040730 Address after: 100036 Beijing city Haidian District Cuiwei Road No. 4 Building No. 4102 Yiyuanju 12 Applicant after: Liu Yuan Address before: 100036 Beijing city Haidian District Cuiwei Road No. 4 Yiyuanju District 12 building 4 door 102 Applicant before: Sanxiong Hi-Tech Development Co Ltd, Beijing |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |